Related Experiment Video
Updated: Mar 1, 2026
09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
1.3K
Bleeding and thrombosis associated with ventricular assist device therapy
Palak Shah1, Udaya S Tantry2, Kevin P Bliden2
1Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, Virginia, USA; Heart Failure and Transplantation, Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
Summary
Continuous-flow pumps improve heart failure survival but cause bleeding and thrombosis. Understanding these complex interactions is key to developing personalized anti-thrombotic strategies for left ventricular assist device (LVAD) patients.
Area of Science:
- Cardiology
- Biomedical Engineering
- Hematology
Background:
- Continuous-flow rotary pumps significantly enhance survival in advanced systolic heart failure patients.
- Left ventricular assist device (LVAD) therapy is limited by bleeding and thrombosis complications.
- The intricate interplay between patient physiology and pump mechanics contributes to adverse events.
Purpose of the Study:
- To elucidate the mechanisms by which continuous-flow pumps induce thrombosis and bleeding.
- To understand the hematologic derangements associated with LVAD therapy.
- To propose personalized anti-thrombotic strategies for LVAD recipients.
Main Methods:
- Review of translational investigations in LVAD patients.
- Analysis of pump-induced activation of coagulation and platelets.
- Examination of high-molecular-weight von Willebrand factor degradation and angiogenesis.
Main Results:
- Continuous-flow pumps activate coagulation and platelets, increasing thrombosis risk.
- Pumps degrade von Willebrand factor and promote abnormal angiogenesis, raising bleeding risk.
- Hematologic derangements like hemolysis and diminished pulsatility contribute to adverse events.
Conclusions:
- Understanding the dual pro-thrombotic and pro-hemorrhagic effects of LVADs is crucial.
- Personalized anti-thrombotic monitoring and anticoagulant titration are needed.
- Novel strategies aim to minimize bleeding and thrombotic events in future LVAD recipients.
Keywords:
anti-thrombotic therapygastrointestinal bleedinghemolysisleft ventricular assisted devicethrombosisMore Related Videos
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
423
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
423
01:30Venous Thrombosis I: Introduction
580
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
580
01:24Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
01:30Venous Thrombosis IV: Nursing Management
324
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
324
01:25Hemodialysis I: Introduction
2.3K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.3K
01:29Cardiomyopathy V: Interprofessional Care
551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551